Dr. Crawford’s principle research interests lie in understanding how alterations in the ubiquitin proteasome system (UPS) contribute to the pathogenesis of Multiple Myeloma and applying this knowledge to identify opportunities for therapeutic intervention.
There are opportunities to investigate molecular mechanisms involved in dysregulation of the ubiquitin proteasome system in multiple myeloma and identify opportunities for therapeutic intervention.
PUBLIC OUTREACH AND KEY ACHIEVEMENTS
Alumni: where are they now?
PhD Title: TRIM E3 ligases in Multiple Myeloma
Years of Study: 2014-2018
Current position: Randox